ESMO 2019: Results from the TRAXAR study to assess TRC105 plus axitinib for metastatic kidney cancer
Results from the TRAXAR clinical trial to assess TRC105 plus [...]
Results from the TRAXAR clinical trial to assess TRC105 plus [...]
TRACON Pharmaceuticals presented final results from a phase 1b clinical trial combining [...]